New Brazilian anti-bribery law carries 'severe penalties' for companies
This article was originally published in Scrip
Executive Summary
Brazil has signed off a landmark anti-bribery law that for the first time subjects pharma companies operating there to sanctions, including stiff fines, for bribing either Brazilian or foreign public officials.